China NT Pharma Group Overview
- Year Founded
-
1995
- Status
-
Public
- Employees
-
32
- Stock Symbol
-
01011
- Investments
-
4
- Share Price
-
$0.03
- (As of Friday Closing)
China NT Pharma Group General Information
Description
China NT Pharma Group Co Ltd is a technology-based pharmaceutical company. It is engaged in research and development, production, and sale of private-label drugs, as well as the provision of pharmaceutical marketing and promotion services in China. It focused on the research, development, production, and sales of orthopedic, psychiatric, and oncology drugs. The Group's operations are regarded as having two operating and reportable segments, namely Agency Services and Healthcare Related Services. The company generates maximum of its revenue from Healthcare Related Services.
Contact Information
Website
www.ntpharma.comCorporate Office
- 28th Floor, Wellington Building
- 198 Wellington Street, Sheung Wan
- Hong Kong
- Hong Kong
Corporate Office
- 28th Floor, Wellington Building
- 198 Wellington Street, Sheung Wan
- Hong Kong
- Hong Kong
China NT Pharma Group Timeline
China NT Pharma Group Stock Performance
As of 20-Nov-2026, China NT Pharma Group’s stock price is $0.03. Its current market cap is $57.3M with 1.8B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.03 | $0.03 | $0.02 - $0.13 | $57.3M | 1.8B | 485K |
China NT Pharma Group Financials Summary
As of 30-Jun-2026, China NT Pharma Group has a trailing 12-month revenue of $5.12M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 79,982 | 114,942 | 57,732 | 134,885 |
| Revenue | 5,120 | 3,359 | 5,290 | 1,041 |
| EBITDA | 163 | 309 | (2,967) | 187 |
| Net Income | (3,940) | (3,621) | (7,436) | (20,296) |
| Total Assets | 94,616 | 49,645 | 45,763 | 46,430 |
| Total Debt | 49,305 | 45,264 | 51,500 | 48,662 |
China NT Pharma Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
China NT Pharma Group Signals
China NT Pharma Group Investments & Acquisitions (4)
China NT Pharma Group’s most recent deal was a Merger/Acquisition with Junbinxiongdi. The deal was made on 28-Aug-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Junbinxiongdi | 28-Aug-2025 | Merger/Acquisition | Holding Companies | ||
| Kangyuan Medical | 05-May-2025 | Merger/Acquisition | Diagnostic Equipment | ||
| Suzhou First Pharmaceutical | 23-Feb-2012 | Corporate | Distributors (Healthcare) | ||
| Suzhou First Pharmaceutical | Merger/Acquisition | Distributors (Healthcare) |
China NT Pharma Group ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Distribution
Subindustry
Rank
Percentile
China NT Pharma Group Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Kangyuan Medical | Hangzhou, China | 2011 |
China NT Pharma Group FAQs
-
When was China NT Pharma Group founded?
China NT Pharma Group was founded in 1995.
-
Where is China NT Pharma Group headquartered?
China NT Pharma Group is headquartered in Hong Kong, Hong Kong.
-
What is the size of China NT Pharma Group?
China NT Pharma Group has 32 total employees.
-
What industry is China NT Pharma Group in?
China NT Pharma Group’s primary industry is Pharmaceuticals.
-
Is China NT Pharma Group a private or public company?
China NT Pharma Group is a Public company.
-
What is China NT Pharma Group’s stock symbol?
The ticker symbol for China NT Pharma Group is 01011.
-
What is the current stock price of China NT Pharma Group?
As of 20-Nov-2026 the stock price of China NT Pharma Group is $0.03.
-
What is the current market cap of China NT Pharma Group?
The current market capitalization of China NT Pharma Group is $57.3M.
-
What is China NT Pharma Group’s current revenue?
The trailing twelve month revenue for China NT Pharma Group is $5.12M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process